Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin pretreatment for prevention of postoperative delirium in elderly orthopedic patients with mild cognitive impairment
ChiCTR2400089093Phase 4Not yet recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) and Mild Cognitive Impairment (MCI) comparing Insulin group with Control group (saline placebo) (2 arms). Primary endpoint: Postoperative delirium incidence rate. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
postoperative delirium (POD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on ChiCTR2400089093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089093.